Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
about
A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosisEpithelial-mesenchymal transition and its implications for fibrosisMesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblastsWNT5A is a regulator of fibroblast proliferation and resistance to apoptosisInhibition and role of let-7d in idiopathic pulmonary fibrosisWNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosisWnt signaling and the developmental fate of lung cellsUp-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosisWnt signalling in lung development and diseasesLung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic ApproachesWnts talking with the TGF-β superfamily: WISPers about modulation of osteoarthritisRole of redoximiRs in fibrogenesisBreakdown of Epithelial Barrier Integrity and Overdrive Activation of Alveolar Epithelial Cells in the Pathogenesis of Acute Respiratory Distress Syndrome and Lung FibrosisDevelopment of anticancer agents targeting the Wnt/β-catenin signalingTrachoma and Ocular Chlamydial Infection in the Era of GenomicsRoles of transcriptional factor 7 in production of inflammatory factors for lung diseasesThe effect of physiological stimuli on sarcopenia; impact of Notch and Wnt signaling on impaired aged skeletal muscle repairRepair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell functionPulmonary fibrosis: patterns and perpetratorsOckham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancerLinking bronchopulmonary dysplasia to adult chronic lung diseases: role of WNT signalingRegulation of Wnt/β-catenin signaling by herpesvirusesEpithelial-mesenchymal transition: An emerging target in tissue fibrosisβ-Catenin Signaling and Roles in Liver Homeostasis, Injury, and TumorigenesisGenetic susceptibility and pulmonary fibrosisRoles for CCN2 in normal physiological processesMatrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosisThe code of non-coding RNAs in lung fibrosisGlobal gene profiling of aging lungs in Atp8b1 mutant miceWilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosisPleural mesothelial cells in pleural and lung diseasesSnail activation disrupts tissue homeostasis and induces fibrosis in the adult kidneyHomeostasis as the Mechanism of EvolutionOn the evolution of developmentActivated Wnt signaling induces myofibroblast differentiation of mesenchymal stem cells, contributing to pulmonary fibrosisGenome-wide association study identifies multiple susceptibility loci for pulmonary fibrosisWNT and beta-catenin signalling: diseases and therapiesThe Impacts of Cellular Senescence in Elderly Pneumonia and in Age-Related Lung Diseases That Increase the Risk of Respiratory Infections.Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).Anti-IFN-γ and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A-specific memory T cells
P2860
Q21135329-74A9BB02-CE49-4427-B20C-17C5657252B3Q24302042-34E06955-3013-40B3-B504-051A0A56A44DQ24313549-A83A027E-9488-4CF3-AF5B-0C743ACF0C8EQ24316338-5BB2577D-3184-49CA-AF94-5DADD9B39D52Q24599153-E896B0F0-6A9D-4907-A0D7-62C60F01A26BQ24650922-70F49EFF-38AD-4F88-AD5C-33D9EB641A41Q24791501-B1593D86-A75F-4808-B39E-D877BC3C180CQ24817140-FC5CD34C-8A8E-47B5-A4CB-38EC5D8DD9CEQ25256712-3240EB3E-4E48-4ADE-8EE3-5B6E181CDD2FQ26770098-E75B25F2-7D14-428E-AFAC-2B18A5DD46E5Q26775922-2BFDAB0A-B4C5-4F57-93B8-F60B1899A612Q26776555-C301EA3C-4121-4138-890E-3EEC35341C86Q26777474-A7ACD085-D78E-480E-90FA-4A6BA4200B1FQ26781898-D56EE46C-27AA-4016-B550-09E05B991578Q26783635-60BAE8BD-934D-47CE-9560-6A22C9776CA1Q26796409-95E9B67D-837A-4E55-A81F-EAC32C7EDF10Q27008819-3CC74458-0AC5-4B84-ACE3-AF51408EF1CAQ27023880-459405A1-8C69-4315-B0B0-4920F1671DD2Q27694249-81B79D15-2D80-4EBD-88DD-CBD4D68DAD32Q28067777-396FF43F-90D5-4903-94B1-68843201A04AQ28075259-A76442CF-562D-4C82-A6EE-8DADE779CE97Q28079414-A69F82AA-56A0-4F4B-9671-6082B71DAF22Q28083351-155E7553-CF99-49E9-A744-FD666B096736Q28087660-78B75BDF-498F-4CA1-A1BB-4E026EF08E34Q28243802-EC4DE8AB-24A1-4938-B723-325DE8251BD3Q28246114-733F814C-D1E2-4ACF-A825-5831150F6362Q28386047-68B4D94B-66E6-455B-8B27-3C5972EC5CE2Q28386827-76DE9CC4-C6DB-4F7C-BF15-F7B40B20AFD4Q28392311-D81E759A-0C34-4D78-9AD0-D54A891A880CQ28396314-A1ADCE4C-D300-4078-917F-B3766C8B9B02Q28396403-E40F96AC-FEF4-4DDE-98E3-8262341B3007Q28505069-2FCC975D-00BD-4A91-9E73-1CB15C820170Q28607085-017CCD2E-A954-4EF5-96B4-17EBB617352DQ28649478-3D04A5DF-95CF-4ACC-A147-AD432C4C1EB9Q28660307-A4819C68-E1EB-4586-BD13-B6378DE0EE29Q28943334-D5DFF791-3F34-49F3-92A0-5AFD26248C1AQ29616159-4044054E-C7B4-4C20-B2BF-CFCC32638DF9Q30235520-4B86CF6B-6E43-4712-ACE2-1C14D469331EQ30422043-6C3A734C-70BB-4FD8-9C0A-CE9363B49188Q30427198-F665E79C-EDA8-4A17-9EB3-0870C102D499
P2860
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
@ast
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
@en
type
label
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
@ast
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
@en
prefLabel
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
@ast
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
@en
P2093
P2860
P50
P1476
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
@en
P2093
Alberto Zamò
Alessandra Cancellieri
Bruno Murer
Claudio Doglioni
Licia Montagna
Manuela Bertaso
Marco Chilosi
Maurizio Lestani
Paola Piccoli
Serena Pedron
P2860
P304
P356
10.1016/S0002-9440(10)64282-4
P407
P577
2003-05-01T00:00:00Z